ESG Inc. financial data

Symbol
ESGH on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
523 School House Rd, Kennett Square, PA
State of incorporation
Nevada
Fiscal year end
December 31
Former names
PLASMA INNOVATIVE INC. (to 11/13/2023)
Latest financial report
10-KT/A - Q4 2023 - Aug 22, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 21.9 % +57.3%
Debt-to-equity 155 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 25.9M shares +67.5%
Common Stock, Shares, Outstanding 25.9M shares +67.5%
Entity Public Float 0 USD
Common Stock, Value, Issued 25.9K USD +67.5%
Weighted Average Number of Shares Outstanding, Basic 25.9M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 25.9M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.51M USD -30.9%
Cost of Revenue 2.08M USD -29.1%
Research and Development Expense 129K USD -26.1%
General and Administrative Expense 145K USD -55%
Operating Income (Loss) 156K USD -24.1%
Nonoperating Income (Expense) -245K USD -101%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 104K USD +28.5%
Net Income (Loss) Attributable to Parent 81.3K USD +43.8%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 135K USD +2526%
Inventory, Net 2.17M USD
Assets, Current 3.88M USD +5862%
Property, Plant and Equipment, Net 769 USD -25.3%
Assets 26.9M USD +40687%
Accounts Payable, Current 3.01M USD +73408%
Liabilities, Current 13.7M USD
Liabilities 15M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -598K USD
Retained Earnings (Accumulated Deficit) -1.73M USD -2111%
Stockholders' Equity Attributable to Parent 8.85M USD +14200%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 11.9M USD -8.31%
Liabilities and Equity 26.9M USD +40687%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 95K USD -80.9%
Net Cash Provided by (Used in) Financing Activities 138K USD
Common Stock, Shares Authorized 65M shares 0%
Common Stock, Shares, Issued 25.9M shares +67.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 491K USD +37.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 135K USD -34.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 150K USD +5.58%
Deferred Tax Assets, Valuation Allowance 2.36M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Depreciation 433K USD +9.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -747K USD -653%
Property, Plant and Equipment, Gross 24.7M USD
Deferred Income Tax Expense (Benefit) -174K USD -35.2%
Deferred Tax Assets, Operating Loss Carryforwards 2.36M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 11.2M USD +8843%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 16.9K USD -2.73%
Depreciation, Depletion and Amortization 453K USD -3.87%
Interest Expense 132K USD -33.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%